Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

OSILODROSTAT vs OXAZEPAM: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

OSILODROSTAT vs OXAZEPAM: Safety Overview

Metric OSILODROSTAT OXAZEPAM
Total FAERS Reports 1,626 12,440
Deaths Reported 191 2,965
Death Rate 11.7% 23.8%
Hospitalizations 526 6,242
Average Patient Age 56.3 yrs 57.3 yrs
% Female Patients 70.8% 58.3%
FDA Approval Date Mar 6, 2020 Approved Prior to Jan 1, 1982
Manufacturer Recordati Rare Diseases, Inc. Aphena Pharma Solutions - Tennessee, LLC
Route ORAL ORAL
Marketing Status Prescription Discontinued